U.S. Monoclonal Antibodies Market Estimations (2025 - 2035)
The U.S. monoclonal antibodies market covers therapeutic monoclonal antibodies sold in the United States, including originator and biosimilar antibodies, naked antibodies, antibody-drug conjugates and bispecifics, given intravenously or subcutaneously, for oncology, autoimmune and inflammatory disease, neurology, infectious disease, hematology and other uses, through hospital, specialty and retail pharmacies.
📄Report ID:2515
|
📊Format: Databook
|
📅Published: 18 November 2026
|
⚡Delivery: Immediate